Kim Hyo-Hyun, Youn Young-Nam
Department of Thoracic & Cardiovascular Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
Division of Cardiovascular Surgery, Severance Cardiovascular Hospital, College of Medicine, Yonsei University, Yonsei University Health System, 250 Seongsanno, Seodaemun-gu, Seoul, 120-752, Republic of Korea.
Sci Rep. 2025 Apr 12;15(1):12663. doi: 10.1038/s41598-025-87675-4.
To compare the Model for End-Stage Liver Disease (MELD), MELD-XI, and Child-Turcotte-Pugh (CTP) scores for risk prediction in patients with cirrhosis undergoing heart transplantation. This study enrolled 66 consecutive patients (26 males; median age, 46 [18-68] years) with liver cirrhosis who underwent heart transplantation at our institution from 1994 to 2022. Potential preoperative outcome predictors and the preoperative MELD, MELD-XI, and CTP scores were calculated. The median follow-up duration was 45.2 months. The MELD (p = 0.01) and MELD-XI scores (p < 0.01) were significantly different between survivors and non-survivors. Cox regression analysis showed that high MELD (hazard ratio [HR] 1.07; 95% confidence interval [CI], 1.03-1.11; p < 0.01), MELD-XI (HR, 1.16; 95% CI, 1.06-1.21; p < 0.01), and CTP scores (HR, 1.43; 95% CI, 1.20-1.75; p = 0.01) were associated with the risk of all-cause mortality. Receiver operating characteristic curve analysis revealed that the optimal cut-off values of MELD, MELD-XI, and CTP scores were 12.2, 12.0, and 7.5, respectively (sensitivity: 69.2, 61.5, and 69.2%; specificity: 68.6, 60.0, and 62.9%, respectively) for all-cause mortality (area under the curve: 0.75, 0.69, and 0.73, respectively). Patients with advanced heart failure and liver cirrhosis have high mortality and morbidity rates after heart transplantation. However, these scoring systems can be used as risk stratification tools in patients with liver cirrhosis undergoing heart transplantation.Research registration unique identifying number: Research Registry (UIN: resarchregistry10791).
比较终末期肝病模型(MELD)、MELD-XI和Child-Turcotte-Pugh(CTP)评分在接受心脏移植的肝硬化患者中的风险预测价值。本研究纳入了1994年至2022年在我院接受心脏移植的66例连续性肝硬化患者(26例男性;中位年龄46[18-68]岁)。计算潜在的术前结局预测指标以及术前MELD、MELD-XI和CTP评分。中位随访时间为45.2个月。幸存者和非幸存者之间的MELD评分(p = 0.01)和MELD-XI评分(p < 0.01)存在显著差异。Cox回归分析显示,高MELD(风险比[HR]1.07;95%置信区间[CI],1.03-1.11;p < 0.01)、MELD-XI(HR,1.16;95%CI,1.06-1.21;p < 0.01)和CTP评分(HR,1.43;95%CI,1.20-1.75;p = 0.01)与全因死亡率风险相关。受试者工作特征曲线分析显示,MELD、MELD-XI和CTP评分预测全因死亡率的最佳截断值分别为12.2、12.0和7.5(敏感性分别为69.2%、61.5%和69.2%;特异性分别为68.6%、60.0%和62.9%)(曲线下面积分别为0.75、0.69和0.73)。晚期心力衰竭和肝硬化患者心脏移植后的死亡率和发病率较高。然而,这些评分系统可作为接受心脏移植的肝硬化患者的风险分层工具。研究注册唯一识别号:研究注册库(UIN:resarchregistry10791)。